A Phase I Study of Surgery Plus Intraoperative Photodynamic Therapy (PDT) in Patients With Resectable, Primary or Recurrent Head and Neck Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs HPPH (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions
- 05 Oct 2018 Biomarkers information updated
- 28 Feb 2013 Planned End Date changed from 1 Jun 2011 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 28 Feb 2013 Status changed from discontinued to active, no longer recruiting as reported by ClinicalTrials.gov.